GHK-Cu (copper peptide): where the research stands
A literature-grounded overview of the copper tripeptide GHK-Cu — its copper-carrier biochemistry, the modern gene-expression research, its skin and matrix biology, and where the evidence is solid versus speculative.
GHK-Cu is one of the older and better-characterised molecules in the research-peptide catalogue. It has been studied since the 1970s, has a genuinely defined biochemistry, and appears in a large body of dermatological and wound-healing literature. That maturity makes it a useful contrast to the many newer compounds whose evidence base is thin.
What it is
GHK-Cu is a copper-binding tripeptide: glycyl-L-histidyl-L-lysine (GHK) complexed with a copper(II) ion. The GHK sequence occurs naturally in human plasma, where its concentration declines with age — a fact that has driven much of the interest in it. The copper complex is the biologically active form studied in most of the literature. Its molecular weight is about 340 g/mol for the tripeptide, and it is usually supplied as a blue-tinted powder or solution, the colour coming from the bound copper.
The mechanistic picture
Copper delivery
A central idea is that GHK acts as a physiological carrier for copper, a trace element required by numerous enzymes involved in tissue remodelling and antioxidant defence. By binding and shuttling copper, GHK-Cu may influence processes that depend on copper availability.
Gene expression
The most striking modern research comes from gene-expression profiling. Studies report that GHK-Cu modulates a large number of human genes, shifting expression patterns in cultured cells toward what the authors describe as a more regenerative, less inflammatory profile. This is the line of work that reignited interest in the molecule in the 2010s.
Matrix and skin biology
In dermal fibroblast cultures, GHK-Cu has been reported to affect the synthesis of collagen, elastin and other extracellular-matrix components, and to influence the enzymes that remodel that matrix. This underpins its long association with skin and wound research.
What has been demonstrated
- Effects on collagen and glycosaminoglycan synthesis in fibroblast cultures.
- Wound-contraction and tissue-repair signals in animal models.
- Broad gene-expression changes in profiling studies of cultured human cells.
- Antioxidant-associated effects in various in-vitro systems.
GHK-Cu is also one of the few compounds in this space with a real cosmetic-ingredient history: the tripeptide appears in topical skincare formulations, a separate regulatory category from research chemicals. That does not translate to any claim for the research-grade material, but it does mean the underlying skin biology has been examined more thoroughly than for most peptides.
What has not happened
Despite the depth of the in-vitro and cosmetic literature, GHK-Cu is not an approved medicine, and the systemic (non-topical) research remains predominantly preclinical. The gene-expression findings are intriguing but are exactly the kind of result that needs independent replication before strong conclusions are drawn.
Specifications you will see
For research use, GHK-Cu is commonly supplied in larger masses than most peptides — 50mg or 200mg vials are typical — reflecting its use in matrix and cell-culture research. The blue tint is normal and comes from the copper. Store cold and dry; see the storage guide for handling.
Bottom line
GHK-Cu is a mature, mechanistically grounded research molecule with a long literature and a clear copper-carrier biochemistry. The modern gene-expression work is what makes it interesting again, and also what most needs replication. As a research tool it is on firmer footing than many trendier compounds.
HelixCore stocks GHK-Cu in 50mg and 200mg vials, 98%+ purity per source specifications. Every batch is tested for identity and purity and the certificate is published on the product page. UK stock, Royal Mail Tracked 24 dispatch, supplied strictly for in-vitro laboratory research use only.